CN1072939C - Medicament for treating primary glomerular disease and its prepn. method - Google Patents
Medicament for treating primary glomerular disease and its prepn. method Download PDFInfo
- Publication number
- CN1072939C CN1072939C CN97102778A CN97102778A CN1072939C CN 1072939 C CN1072939 C CN 1072939C CN 97102778 A CN97102778 A CN 97102778A CN 97102778 A CN97102778 A CN 97102778A CN 1072939 C CN1072939 C CN 1072939C
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- medicine
- restrains
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to medicament for treating primary glomerular diseases and a preparation method thereof. The present invention relates to a traditional Chinese medicine preparation for treating primary glomerular diseases and a preparation method thereof. The present invention adopts tripterygium wilfordii, acanthopanax bark, bupleurum root, scutellaria root, radix, achyranthes root, angelica, red sage root, chuanxiong rhizome, leech, etc. as main raw material. Proper medicine is added into medicament for treating different kinds of kidney diseases. The medicament has obvious therapeutic effect for various kinds of primary glomerular diseases.
Description
The present invention relates to a kind of Chinese medicine preparation and pharmaceutical methods thereof for the treatment of primary glomerulopathy.
At present the medicament of treatment primary glomerulopathy roughly can be divided into two kinds in Chinese medicine and Western medicine, and the differential diagnosis in tcm opinion is controlled, except the acute nephritis curative effect better, then undesirable to the nephritis treatment effect of some other type; Western medicine is certain to some renal glomerular disease curative effect, but long-term the extensive application has significant side effects, and is also undesirable to the therapeutic effect of some type nephritis.
The objective of the invention is to develop a kind of have certain antibiotic, antiviral, antiallergic action and antiinflammatory; mediator's body immunity function; improve the glomerule hematodinamics, protect and recovery renal corpuscle proximal convoluted tubule cell function, primary glomerulopathy is had the Chinese medicine preparation of obvious curative effects.
First kind of prescription realizing purpose of the present invention is: Radix Tripterygii Wilfordii 4 restrains, Cortex Acanthopancis 5 restrains, Radix Bupleuri 5 restrains, Radix Scutellariae 3 restrains, Radix Rhapontici 5 restrains, cattle sunset 7 restrain, Radix Angelicae Sinensis 5 restrains, Radix Salviae Miltiorrhizae 8 restrains, Rhizoma Chuanxiong 4 restrains, Hirudo 0.5 restrains;
Method for making: 1. Hirudo porphyrize powder; 2. Radix Tripterygii Wilfordii (peeling) decocting is 2 hours, gets the filtrate concentrate drying; 3. all the other eight flavor medicine Hybrid Heating water extractions, the filtrate concentrate drying is mixed with Hirudo powder with 2. mixing pulverizing again, makes enteric coated tablet.This is a dose, and treatment latent nephritis day is obeyed secondary, 15 days one courses of treatment.
The treatment acute nephritis will add Flos Lonicerae 6 gram, Fructus Forsythiae 6 grams in first kind of prescription, eight water of distinguishing the flavor of in the medicines together that this two medicine adds are up carried, and all the other (comprising method for making etc.) are identical with first kind of prescription; This is a dose, obeys once in 8 hours, and 10 days is a course of treatment.
Treat radical nephritis and will add Flos Lonicerae 15 gram, Fructus Forsythiae 10 grams in first kind of prescription, this two medicine is added in the eight flavor medicines of first kind of prescription together water and carries, all the other (comprising method for making etc.) and first fill a prescription identical; This also is a dose, and 6 hours once, and 15 days is a course of treatment.
The treatment chronic nephritis is to add Radix Codonopsis 5 grams, the Radix Astragali 10 grams in first kind of prescription, this two medicine is added in the eight flavor medicines of first kind of prescription together water and carries, and all the other (comprising method for making etc.) are identical with first kind of prescription; This also is a dose, day clothes secondary, one month one course of treatment.
The treatment nephrotic syndrome is to add Radix Codonopsis 5 grams, the Radix Astragali 20 grams, Semen Cuscutae 10 grams in first kind of prescription, this three medicine is added in the eight flavor medicines of first kind of prescription together water and carries, and all the other (comprising method for making etc.) are identical with first kind of prescription; This also is a dose, day clothes secondary, one month one course of treatment.
Use above-mentioned each medicament to note: 1, acute nephritis acute and chronic renal failure etc. occurs as hyperpyrexia, heart failure, hypertensive encephalopathy and primary glomerulopathy occurring, should handle to the ill.2, anemia of pregnant woman, menstrual phase women have bleeding tendency person to avoid usefulness.3, the careful usefulness of menorrheal usually women.
Advantage of the present invention is to have antibiotic, antiviral, antiallergic action and antiinflammatory, and mediator's body immunity function improves the glomerule hematodinamics, protection and recover renal corpuscle, and the proximal convoluted tubule cell function has obvious curative effects to primary glomerulopathy.
Embodiment one is 1.. water intaking trematodiasis 0.5 gram levigation; 2.. Radix Tripterygii Wilfordii (peeling) 4 grams, decocting 2 hours is got secondary filtrate concentrate drying; 3.. get Cortex Acanthopancis 5 gram, Radix Bupleuri 5 grams, Radix Scutellariae 3 grams, Radix Rhapontici 5 grams, cattle sunset 7 gram, Radix Angelicae Sinensis 5 grams, Radix Salviae Miltiorrhizae 8 grams, Rhizoma Chuanxiong 4 grams, this eight flavors medicine Hybrid Heating water is carried the filtrate concentrate drying; To 2. 3. mix to pulverize and 1. be mixed and make enteric coated tablet.
Embodiment two is basic identical with example one, just increases Flos Lonicerae 6 grams in 3., Fructus Forsythiae 6 grams, and all the other (comprising pharmaceutical methods etc.) are all identical with example one.
Embodiment three is basic identical with example one, just increases Flos Lonicerae 15 grams, Fructus Forsythiae 10 grams in 3., and all the other (comprising pharmaceutical methods etc.) are all identical with example one.
Embodiment four is basic identical with example one, just increases Radix Codonopsis 5 grams, Radix Astragali 10 grams in 3., and all the other (comprising pharmaceutical methods etc.) are all identical with example one.
Embodiment five and example one are basic identical, just increase Radix Codonopsis 5 grams in 3., and Radix Astragali 20 grams, Semen Cuscutae 10 restrain, all the other (comprising pharmaceutical methods etc.) are all identical with example one.
Claims (4)
1. medicine for the treatment of primary glomerulopathy, it is characterized in that by Radix Tripterygii Wilfordii 4 gram, Cortex Acanthopancis 5 grams, Radix Bupleuri 5 grams, Radix Scutellariae 3 grams, Radix Rhapontici 5 grams, cattle sunset 7 gram, Radix Angelicae Sinensis 5 grams, Radix Salviae Miltiorrhizae 8 grams, Rhizoma Chuanxiong 4 grams, Hirudo 0.5 gram make as follows: with Hirudo porphyrize powder, Radix Tripterygii Wilfordii was removed the peel decocting 2 hours, get the filtrate concentrate drying, all the other 8 flavor Hybrid Heating water are carried, and the filtrate concentrate drying mixes pulverizing with Radix Tripterygii Wilfordii extract, with the Hirudo powder mixing, make enteric coated tablet again.
2. the medicine of treatment primary glomerulopathy according to claim 1 is characterized in that adding Flos Lonicerae 6 grams and Fructus Forsythiae 6 in the medicines again at 8 flavors that Hybrid Heating water is carried restrains together water and carry.
3. the medicine of treatment primary glomerulopathy according to claim 1 is characterized in that adding Radix Codonopsis 5 grams and the Radix Astragali 10 in the medicines again at 8 flavors that Hybrid Heating water is carried restrains together water and carry.
4. the medicine of treatment primary glomerulopathy according to claim 1 is characterized in that adding Radix Codonopsis 5 grams, the Radix Astragali 20 grams, Semen Cuscutae 10 in the medicines again at 8 flavors that Hybrid Heating water is carried restrains together water and carry.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97102778A CN1072939C (en) | 1997-04-18 | 1997-04-18 | Medicament for treating primary glomerular disease and its prepn. method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97102778A CN1072939C (en) | 1997-04-18 | 1997-04-18 | Medicament for treating primary glomerular disease and its prepn. method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1196936A CN1196936A (en) | 1998-10-28 |
| CN1072939C true CN1072939C (en) | 2001-10-17 |
Family
ID=5166437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97102778A Expired - Fee Related CN1072939C (en) | 1997-04-18 | 1997-04-18 | Medicament for treating primary glomerular disease and its prepn. method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1072939C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8055203B2 (en) * | 2007-03-14 | 2011-11-08 | Mks Instruments, Inc. | Multipoint voltage and current probe system |
| CN104997852A (en) * | 2015-09-02 | 2015-10-28 | 济南知尔医药科技有限公司 | Traditional Chinese medicine composition for treating glandular cystitis |
| CN106963843A (en) * | 2017-04-20 | 2017-07-21 | 石家庄肾病医院股份有限公司 | Lift the Chinese medicine composition and its application method of human peripheral blood regulatory T cells |
-
1997
- 1997-04-18 CN CN97102778A patent/CN1072939C/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| vol. 6, no. 5, 1 January 1984 (1984-01-01), pages 31 * |
| 福建医药杂志1984,6(5) 1984.01.01 李玉珍 谢福安 雷公藤治疗肾小球性肾炎31例疗效观察 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1196936A (en) | 1998-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101380417B (en) | Preparation for quickly treating urticaria | |
| CN100356972C (en) | Chinese medicine for treating amblyopia and myopia | |
| CN100496586C (en) | Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
| CN1054530C (en) | Qianliehuixiao pill for treating prostatitis and prostatic hyperplasia | |
| CN103169805A (en) | Medicament for treating meniscus injury | |
| CN101569739B (en) | Traditional Chinese medicine composition for treating cholecystitis and preparation method thereof | |
| CN101485803B (en) | Chinese medicinal composition for treating menoxenia and dysmenorrhea | |
| CN101987138A (en) | Chinese medicinal preparation for treating impotence | |
| CN1332702C (en) | Medicine for treating psoriasis | |
| CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
| CN1072939C (en) | Medicament for treating primary glomerular disease and its prepn. method | |
| CN1320914C (en) | Menstruation regulating powder | |
| CN1056064C (en) | Medicine for curing liver cancer and its making method | |
| CN1332707C (en) | Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B | |
| CN101181564A (en) | Chinese medicine compound preparations with antineoplastic activity | |
| CN101856423A (en) | Medicament for treating menoxenia and preparation method thereof | |
| CN1125111A (en) | Chinese proprietary medicine for curing stomach trouble, duodenal ulcer and chronic gastritis | |
| CN1240415C (en) | Tablets against allergic purpura | |
| CN101703645B (en) | Chinese medicinal composition for treating cervical vertebra hyperosteogeny | |
| CN110721218A (en) | Traditional Chinese medicine composition for treating diabetes and application thereof | |
| CN103893629A (en) | Chinese medicinal composition for treating child anorexia | |
| CN102335243B (en) | Chinese medicinal composition for treating icteric hepatitis | |
| CN102366594A (en) | Traditional Chinese medicine for adjusting menstruation | |
| CN110123896B (en) | Pharmaceutical composition for adjuvant treatment of tumor and preparation method thereof | |
| CN105031321A (en) | Traditional Chinese medicine for treating bone tumour |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |